Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, which is engaged in the discovery, development and commercialization of biologic therapeutic products aimed at treating patients with severe and life-threatening disease states, including hematologic, kidney and neurologic diseases, transplant rejection, cancer and autoimmune disorders. 

Biotechnology

Alexion Pharmaceuticals

Ludwig N. Hantson

Patryk Mikucki

Toby Freyman

Chad Trexler

Indrani Franchini

Jim Redmond

Morgan Sanford

Aradhana Sarin

Clinical Development and Medical Affairs

Global Commercial Strategy and Operations

Leadership Team

Teams at Alexion Pharmaceuticals

Clinical Development and Medical Affairs

Global Commercial Strategy and Operations

Leadership Team